Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

November 2022; Volume 42,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abe, KAZUNOBU

    1. You have access
      Intravascular Administration of Acridine Orange and Zoledronate in a Bone Metastasis Model of Breast Cancer
      RYO SHOJI, HIROYUKI TSUCHIE, HIROYUKI NAGASAWA, MICHIO HONGO, YUJI KASUKAWA, KOJI NOZAKA, DAISUKE KUDO, HIKARU SAITO, KAZUNOBU ABE, SHUN IGARASHI, SHUNTARO HARATA, FUMIHITO KASAMA and NAOHISA MIYAKOSHI
      Anticancer Research November 2022, 42 (11) 5357-5363; DOI: https://doi.org/10.21873/anticanres.16041
  2. Aggerholm-pedersen, NINNA

    1. You have access
      Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour – A Methodological Assessment Study
      CHARLOTTE MARGARETA BRINCH, NINNA AGGERHOLM-PEDERSEN, TIM SVENSTRUP POULSEN, WOJCIECH SKOVRIDER-RUMINSKI, PIETER DE HEER, LUIT PENNINGA, ANDERS KRARUP-HANSEN and ESTRID HOGDALL
      Anticancer Research November 2022, 42 (11) 5527-5537; DOI: https://doi.org/10.21873/anticanres.16022
  3. Akahane, TAKEMI

    1. You have access
      Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
      SOICHI TAKEDA, TADASHI NAMISAKI, YUKI TSUJI, YUKI FUJIMOTO, KOJI MURATA, MASAHIDE ENOMOTO, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, KOH KITAGAWA, HIROAKI TAKAYA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI
      Anticancer Research November 2022, 42 (11) 5465-5473; DOI: https://doi.org/10.21873/anticanres.16051
  4. Akimoto, EIGO

    1. You have access
      The Significance of Staging Laparoscopy in Detection of Radiologically Occult Peritoneal Carcinomatosis in Gastric Cancer With Gastric Outlet Obstruction: Consideration of The Optimal Treatment Approach
      MASARU KOMATSU, TAKAHIRO KINOSHITA, EIGO AKIMOTO, MITSUMASA YOSHIDA, DAIKI TERAJIMA, HIROMI NAGATA, TAKUMI HABU, TAKAFUMI OKAYAMA, YUYA TAKABE, JUNICHIRO HARADA, MASAYUKI YAMAGUCHI and MASAHIRO YURA
      Anticancer Research November 2022, 42 (11) 5571-5578; DOI: https://doi.org/10.21873/anticanres.16064
  5. Akimoto, KAZUNORI

    1. Open Access
      High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer
      YUYUN XIONG, HITOMI MOTOMURA, SHOMA TAMORI, AYAKA OZAKI, CHOTARO ONAGA, YASUSHI HARA, KEIKO SATO, KOUJI TAHATA, YOHSUKE HARADA, KAZUNORI SASAKI, YUN-WEN ZHENG, SHIGEO OHNO and KAZUNORI AKIMOTO
      Anticancer Research November 2022, 42 (11) 5223-5232; DOI: https://doi.org/10.21873/anticanres.16029
  6. Akiyama, YASUTO

    1. Open Access
      Development of Novel Small Antitumor Compounds Inhibiting PD-1/PD-L1 Binding
      YASUTO AKIYAMA, TADASHI ASHIZAWA, AKIRA IIZUKA, TAKAYUKI ANDO, YOSHINOBU ISHIKAWA, RYOTA KONDOU, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TAKASHI SUGINO and KEN YAMAGUCHI
      Anticancer Research November 2022, 42 (11) 5233-5247; DOI: https://doi.org/10.21873/anticanres.16030
  7. Al-khudari, SAMER

    1. You have access
      Impact of Routine Surveillance Imaging on Recurrence in Sinonasal Malignancies
      KEVIN KING, RYAN RAUCH, SOUMYAJIT ROY, OLEG MENYOK, KEN TATEBE, BOBBY TAJUDEEN, PETER PAPAGIANNOPOULOS, PETE S. BATRA, MIHIR BHAYANI, SAMER AL-KHUDARI, KIRSTEN STENSON, MICHAEL J. JELINEK, MARY JO FIDLER and NIKHIL JOSHI
      Anticancer Research November 2022, 42 (11) 5449-5455; DOI: https://doi.org/10.21873/anticanres.16049
  8. Alonsozana, EDGAR

    1. You have access
      Molecular Characteristics and Immunogenomic Profiling of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma in a 68-year-old Patient
      GRACE HUANG, LEONARD N. HOWARD, EDGAR ALONSOZANA, DAVID SILL, DEBASHISH BOSE and JINPING LAI
      Anticancer Research November 2022, 42 (11) 5475-5478; DOI: https://doi.org/10.21873/anticanres.16052
  9. An, JU-HYUN

    1. You have access
      Effects of Cyclooxygenase-2 in Canine Melanoma-derived Extracellular Vesicles on Tumor Microenvironment In Vitro
      NA-HYEONG KIM, JU-HYUN AN, JEONG-HWA LEE, SU-MIN PARK, KYEONG-BO KIM, TAE-HYUN KIM, YE-IN OH, KYEONG-WON SEO and HWA-YOUNG YOUN
      Anticancer Research November 2022, 42 (11) 5397-5405; DOI: https://doi.org/10.21873/anticanres.16044
  10. Ando, TAKAYUKI

    1. Open Access
      Development of Novel Small Antitumor Compounds Inhibiting PD-1/PD-L1 Binding
      YASUTO AKIYAMA, TADASHI ASHIZAWA, AKIRA IIZUKA, TAKAYUKI ANDO, YOSHINOBU ISHIKAWA, RYOTA KONDOU, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TAKASHI SUGINO and KEN YAMAGUCHI
      Anticancer Research November 2022, 42 (11) 5233-5247; DOI: https://doi.org/10.21873/anticanres.16030
« Previous (Pages : 1 2 3 4 5 6 ... 46) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (11)
Anticancer Research
Vol. 42, Issue 11
November 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Inhibition of STAT3 Promotes Effector T Cell Infiltration But also Immunosuppression in the HCC Tumor Microenvironment
  • Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ Agonists
  • Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-type Gastric Cancer
  • Prognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma
  • Letermovir Prophylaxis for CMV Reactivation in Allogeneic Stem Cell Recipients: A Retrospective Single Center Analysis
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire